CareDx logo.jpg
CareDx to Report Third Quarter 2021 Financial Results
October 14, 2021 16:01 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
AlloSure, the First dd-cfDNA in Heart and Kidney Transplantation, Launches for Lung Transplant Patients
October 12, 2021 10:18 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication
September 30, 2021 16:01 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
CareDx Continues to Fight for Innovation in Transplantation
September 28, 2021 19:18 ET | CareDx, Inc.
False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc....
CareDx logo.jpg
CareDx Presents Latest Data on AlloSeq Portfolio at ASHI 2021
September 27, 2021 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
CareDx Names Longtime Patient Advocate Art Torres to Board of Directors
September 15, 2021 08:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
CareDx to Participate in Upcoming Conferences
September 02, 2021 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
CareDx Showcases Leadership in Global Transplantation at ESOT 2021
August 26, 2021 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance
July 29, 2021 16:01 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx logo.jpg
CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients
July 26, 2021 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...